Department of Health written question – answered on 4th January 2016.
Lord Hunt of Kings Heath
Shadow Spokesperson (Health), Shadow Deputy Leader of the House of Lords
To ask Her Majesty’s Government how they plan to ensure that, in the implementation of the NHS Supply Chain generic project plans for a national formulary for wound care, innovative small companies are not at a disadvantage in bidding for contracts.
Lord Prior of Brampton
The Parliamentary Under-Secretary of State, Department of Health
Innovation is welcomed as part of this process and the clinical specifications may support smaller companies who demonstrate their capability to meet the requirements. One advantage of the NHS Supply Chain venture for smaller companies is that it can act as a single point of entry into the National Health Service and lower the ‘cost of sales’.
Yes0 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
